Key drivers included high demand for Zoetis’ companion animal products, such as Librela and Solensia, targeting osteoarthritis in pets, and Simparica Trio for flea, tick, and heartworm protection.

Zoetis ( (ZTS)) has shared an announcement. Zoetis Inc., a leader in animal health, is undergoing significant leadership changes to accelerate growth and enhance itsglobal marketpresence. Jamie ...

Parsippany, New Jersey-based Zoetis Inc. (ZTS) discovers, develops, and commercializes animal health medicines, vaccines, and diagnostic products and services. With a market cap of $79.9 billion ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic ...

ANIMAL health company Zoetis has completed its annual fund-raiser for the Beyond Blue foundation, supporting mental health in rural and regional areas of Australia, raising another $100,000 for the ...

After hours: November 15 at 7:59 PM EST Loading Chart for ZTS ...

Sign up for our weekly emails to instantly know what’s happening at every level of the veterinary profession. Sign up We’re committed to your privacy. Veterinary ...